Free Trial
OTCMKTS:NRNVF

Nordic Nanovector ASA (NRNVF) Stock Price, News & Analysis

$1.64 0.00 (0.00%)
As of 10/18/2021

About Nordic Nanovector ASA Stock (OTCMKTS:NRNVF)

Key Stats

Today's Range
$1.64
$1.64
50-Day Range
$1.64
$1.64
52-Week Range
$1.64
$1.64
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nordic Nanovector ASA, a biopharmaceutical company, develops and commercializes therapeutics for hematological cancers in Norway and internationally. The company's lead product candidate is Betalutin, a CD37-targeting antibody-radionuclide-conjugate, which is in Phase 2b clinical trial for the treatment of patients with non-hodgkin lymphoma. Its preclinical development product also includes Alpha37, an anti-CD37 alphaparticle emitting radioimmunoconjugate for treating chronic lymphatic leukemia. Nordic Nanovector ASA has collaboration agreements with Paul Scherrer Institute; Areva Med; LegoChem Bio; and Heidelberg Pharma. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.

Receive NRNVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nordic Nanovector ASA and its competitors with MarketBeat's FREE daily newsletter.

NRNVF Stock News Headlines

Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
See More Headlines

NRNVF Stock Analysis - Frequently Asked Questions

Nordic Nanovector ASA's stock was trading at $1.6383 at the start of the year. Since then, NRNVF shares have increased by 0.0% and is now trading at $1.6383.
View the best growth stocks for 2025 here
.

Shares of NRNVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:NRNVF
CIK
N/A
Fax
N/A
Employees
39
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:NRNVF) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners